Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer
Fig 7
KRAS gene expression and protein levels in MCF-7, MDA MB-231, and T-47D breast cancer cells treated with ribitol.
A) KRAS expression in MCF-7 cell line by Real-Time qRT-PCR B) Relative KRAS expression in MDA MB-231 and T-47D breast cancer cell lines by Real-Time qRT-PCR C) KRAS protein expression by western blot of control, and ribitol-treated breast cancer cell lines MDA MB-231, MCF-7, and T-47D (D) Relative KRAS expression in xenograft MCF-7 tumors after ribitol treatment by Real-Time qRT-PCR.